AR016987A1 - Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a - Google Patents

Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a

Info

Publication number
AR016987A1
AR016987A1 ARP990102002A ARP990102002A AR016987A1 AR 016987 A1 AR016987 A1 AR 016987A1 AR P990102002 A ARP990102002 A AR P990102002A AR P990102002 A ARP990102002 A AR P990102002A AR 016987 A1 AR016987 A1 AR 016987A1
Authority
AR
Argentina
Prior art keywords
hepatitis
profilaxis
vaccine
water vaccine
waterproof
Prior art date
Application number
ARP990102002A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of AR016987A1 publication Critical patent/AR016987A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se trata de composiciones de vacunas que comprenden un antígeno de la hepatitis B formulado con fosfato de aluminio. Dichas composiciones de vacuna puedencontener además virus inactivados de la hepatitis A, hidroxido de aluminio y formaldehído. Las formulaciones de vacuna combinada para la hepatitis A y B sonadministrables a sujetos humanos en una pauta de inmunizacion de dos dosis.
ARP990102002A 1998-05-01 1999-04-29 Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a AR016987A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition

Publications (1)

Publication Number Publication Date
AR016987A1 true AR016987A1 (es) 2001-08-01

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102002A AR016987A1 (es) 1998-05-01 1999-04-29 Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a

Country Status (29)

Country Link
EP (1) EP1073462B1 (es)
JP (2) JP5138843B2 (es)
KR (1) KR100612547B1 (es)
CN (1) CN1263509C (es)
AR (1) AR016987A1 (es)
AT (1) ATE345815T1 (es)
AU (1) AU743759B2 (es)
BR (1) BR9910157A (es)
CA (1) CA2331086C (es)
CO (1) CO5050367A1 (es)
CY (1) CY1107322T1 (es)
CZ (1) CZ301232B6 (es)
DE (1) DE69934108T2 (es)
DK (1) DK1073462T3 (es)
ES (1) ES2277437T3 (es)
GB (1) GB9809507D0 (es)
GC (1) GC0000101A (es)
HK (1) HK1034202A1 (es)
HU (1) HU228209B1 (es)
IL (1) IL139269A0 (es)
MY (1) MY128929A (es)
NO (1) NO20005483L (es)
NZ (1) NZ507902A (es)
PL (1) PL190729B1 (es)
PT (1) PT1073462E (es)
TR (1) TR200003235T2 (es)
TW (1) TW553744B (es)
WO (1) WO1999056772A2 (es)
ZA (1) ZA200006118B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
HU220236B (hu) * 1992-05-23 2001-11-28 Smithkline Beecham Biologicals S.A. Hepatitis B felszíni antigént és egyéb antigéneket tartalmazó, kombinált oltóanyagok
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
JP4229341B2 (ja) * 1996-03-23 2009-02-25 財団法人阪大微生物病研究会 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン

Also Published As

Publication number Publication date
DE69934108T2 (de) 2007-04-19
GC0000101A (en) 2005-06-29
PT1073462E (pt) 2007-01-31
MY128929A (en) 2007-02-28
ATE345815T1 (de) 2006-12-15
CZ301232B6 (cs) 2009-12-16
HU228209B1 (en) 2013-01-28
EP1073462B1 (en) 2006-11-22
AU4137999A (en) 1999-11-23
ES2277437T3 (es) 2007-07-01
KR20010043224A (ko) 2001-05-25
AU743759B2 (en) 2002-02-07
BR9910157A (pt) 2001-01-09
JP2002513771A (ja) 2002-05-14
NO20005483D0 (no) 2000-10-31
JP5138843B2 (ja) 2013-02-06
KR100612547B1 (ko) 2006-08-11
PL190729B1 (pl) 2005-12-30
DE69934108D1 (de) 2007-01-04
TR200003235T2 (tr) 2001-03-21
WO1999056772A3 (en) 2000-02-03
ZA200006118B (en) 2002-01-30
NZ507902A (en) 2002-03-28
NO20005483L (no) 2000-12-08
HK1034202A1 (en) 2001-10-19
CZ20004061A3 (cs) 2001-04-11
EP1073462A2 (en) 2001-02-07
JP2010209118A (ja) 2010-09-24
TW553744B (en) 2003-09-21
HUP0101652A3 (en) 2004-10-28
CN1308547A (zh) 2001-08-15
HUP0101652A1 (hu) 2001-09-28
CA2331086C (en) 2010-06-22
GB9809507D0 (en) 1998-07-01
CO5050367A1 (es) 2001-06-27
DK1073462T3 (da) 2007-02-26
CA2331086A1 (en) 1999-11-11
WO1999056772A2 (en) 1999-11-11
CN1263509C (zh) 2006-07-12
PL344137A1 (en) 2001-10-08
IL139269A0 (en) 2001-11-25
CY1107322T1 (el) 2012-11-21

Similar Documents

Publication Publication Date Title
DE60121136D1 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
AR025502A1 (es) Composicion de vacuna adecuada para usar en el tratamiento o la profilaxis de infecciones de virus del papiloma humano e infecciones de virus del herpes simple.
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
BR9908599A (pt) Composições combinadas de vacina
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
DK1326636T3 (da) Vaccinesammensætning
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
WO2002013855A3 (en) Vaccines containing ribavirin and methods of use thereof
ITMI913092A0 (it) Vaccino di poxvirus ricombinate del virus del morbillo
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
BR0212312A (pt) Clone infeccioso do vìrus da diarréia viral bovina
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
DE69102649D1 (de) Hrsv-vakzine.
DK0563288T3 (da) Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner
AR229930A1 (es) Procedimiento para estabilizar una vacuna que comprende un virus vivo,inactivado o atenuado de sarampion,papera,rubeola o combinaciones de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure